[Plasma fibrinogen as a cardiovascular risk factor]

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Epidemiology

Context:

• Plasma fibrinogen is an established independent risk factor for arteriosclerotic diseases, including ischemic heart disease, stroke, and peripheral vascular disease.
• Existing studies show correlations between fibrinogen levels and factors such as age, gender, race, and smoking habits.
• Fibrinogen and its byproducts directly influence vascular wall biology, impacting smooth muscle cell migration and proliferation, key processes in atherosclerosis and thrombus organization.

Purpose:

• To explore the complex relationship between hyperfibrinogenemia, atherosclerosis, and thrombosis.
• To investigate the predictive value of plasma fibrinogen levels for cardiovascular disorders.
• To address the lack of prospective studies on fibrinogen and cardiovascular outcomes in the Japanese population.

Summary:

• Plasma fibrinogen significantly impacts blood coagulation, rheology, and platelet aggregation.
• Vascular smooth muscle cells interact with fibrinogen/fibrin, undergoing chemotaxis and haptotaxis, which are crucial for atherosclerotic plaque development and thrombus organization.
• Prospective epidemiological studies highlight fibrinogen as a potent risk factor for major vascular diseases.

Impact:

• Understanding the role of plasma fibrinogen in cardiovascular disorders may offer new insights into their pathophysiological mechanisms.
• This research could lead to improved risk stratification and preventative strategies for arteriosclerotic diseases.
• Findings may have implications for public health initiatives targeting cardiovascular disease prevention in diverse populations.